IRIS UniCatt

Mastrangelo, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.350
AS - Asia 4.205
EU - Europa 3.087
SA - Sud America 804
AF - Africa 100
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.195
SG - Singapore 1.945
DE - Germania 956
CN - Cina 807
BR - Brasile 675
IT - Italia 404
VN - Vietnam 403
SE - Svezia 397
FR - Francia 307
IN - India 237
UA - Ucraina 172
GB - Regno Unito 155
IE - Irlanda 152
JP - Giappone 138
FI - Finlandia 133
PL - Polonia 126
BD - Bangladesh 104
HK - Hong Kong 95
ID - Indonesia 95
RU - Federazione Russa 78
TR - Turchia 73
AR - Argentina 58
CA - Canada 58
MX - Messico 56
IQ - Iraq 46
KR - Corea 43
NL - Olanda 39
PK - Pakistan 33
ES - Italia 31
ZA - Sudafrica 26
AT - Austria 25
SA - Arabia Saudita 21
EC - Ecuador 20
BE - Belgio 19
IR - Iran 16
UZ - Uzbekistan 16
IL - Israele 13
JO - Giordania 13
MA - Marocco 13
CO - Colombia 12
CZ - Repubblica Ceca 12
AU - Australia 11
EG - Egitto 11
KE - Kenya 11
NP - Nepal 11
PH - Filippine 11
RO - Romania 11
CH - Svizzera 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
LT - Lituania 9
MY - Malesia 9
VE - Venezuela 9
HN - Honduras 8
KG - Kirghizistan 8
OM - Oman 8
GE - Georgia 7
PE - Perù 7
BG - Bulgaria 6
ET - Etiopia 6
JM - Giamaica 6
KZ - Kazakistan 6
TH - Thailandia 6
AL - Albania 5
CL - Cile 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EU - Europa 5
GR - Grecia 5
PA - Panama 5
TW - Taiwan 5
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
GH - Ghana 4
HU - Ungheria 4
LB - Libano 4
MD - Moldavia 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
UY - Uruguay 4
CI - Costa d'Avorio 3
GA - Gabon 3
HR - Croazia 3
KW - Kuwait 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BY - Bielorussia 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
RS - Serbia 2
Totale 12.541
Salva come PNG Salva come JPEG
Città #
Singapore 1.042
San Jose 544
Ashburn 505
Chandler 421
Beijing 162
New York 153
Hefei 148
Dublin 147
Ho Chi Minh City 137
Tokyo 125
Lauterbourg 119
Los Angeles 102
Warsaw 101
Jacksonville 97
Hyderabad 96
San Mateo 96
Hanoi 94
Jakarta 87
Rome 85
Hong Kong 79
Helsinki 75
Fairfield 66
The Dalles 65
Frankfurt am Main 64
Council Bluffs 61
Wilmington 61
Houston 59
Ann Arbor 58
Nürnberg 57
Nanjing 50
Moscow 49
Boston 46
Kent 46
Milan 46
Chicago 44
Woodbridge 44
Santa Clara 43
Dallas 42
Bremen 41
Munich 41
Seoul 41
Seattle 40
São Paulo 39
Princeton 36
Chennai 35
Memphis 34
Buffalo 33
Redwood City 33
London 31
Dearborn 29
Atlanta 27
Boardman 27
Cattolica 27
Paris 27
Dhaka 26
Istanbul 24
Nuremberg 23
Rio de Janeiro 23
Da Nang 21
Montreal 21
Orem 21
Denver 20
Nanchang 20
Ankara 19
Baghdad 18
Brooklyn 18
Düsseldorf 16
Haiphong 16
Mexico City 16
Roubaix 16
Brussels 15
Johannesburg 15
Lawrence 15
Marseille 15
Mountain View 15
Mumbai 15
Phoenix 15
Tashkent 15
Brasília 14
Fremont 14
Kraków 14
Norwalk 14
Shanghai 14
Stockholm 14
Biên Hòa 13
Cambridge 13
Izmir 13
Lappeenranta 13
Pune 13
San Francisco 13
Amman 12
Amsterdam 12
Porto Alegre 12
Belo Horizonte 11
Bexley 11
Changsha 11
Detroit 11
Hebei 10
Karachi 10
Lahore 10
Totale 6.567
Salva come PNG Salva come JPEG
Nome #
Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors 301
Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer 226
Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise? 208
Managing children with brain tumors during the COVID-19 era: Don't stop the care! 199
Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed) 188
CYTOTOXICITY OF PACLITAXEL AND DOCETAXEL IN HUMAN NEUROBLASTOMA CELL-LINES 185
Impact of malnutrition on survival and infections among pediatric patients with cancer: a retrospective study. 185
Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of (131) I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen. 183
A NEW APPROACH IN THE TREATMENT OF STAGE-IV NEUROBLASTOMA USING A OMBINATION OF {[I-131] METAIODOBENZYLGUANIDINE (MIBG) AND CISPLATIN} 180
Platinum compounds and sodium metabolism in children with diencephalic glioma 179
Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection 176
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors 168
Two cases of pediatric high-grade astroblastoma with different clinical behavior 165
Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis 162
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma 160
Role of {[I-131]metaiodobeuzylguanidine (MIBG) in the treatment of neuroblastoma: A review} 159
Could APC gene screening be useful in children with hepatoblastoma? Early onset of adenocarcinoma in a child with familial adenomatous polyposis and hepatoblastoma 156
Early reactive neutrophil changes in an infant with Kawasaki syndrome. 155
The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study 155
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma 154
The role of diet on the clinical pharmacology of oral antineoplastic agents 148
Management of children with thrombocytopenia-absent radius syndrome: an institutional experience 147
Constitutional trisomy 8 and myelodysplasia: report of a case and review of the literature 147
Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome 147
Errors involving patients receiving intrathecal chemotherapy 144
Central pontine and extrapontine myelinolysis in a pediatric patient following rapid correction of hypernatremia 144
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers 140
CARBOPLATIN IN CHILDHOOD MEDULLOBLASTOMA PNET - FEASIBILITY OF AN IN-VIVO SENSITIVITY TEST IN AN UP-FRONT STUDY 138
Carboplatin-related toxicity in children with cancer 137
[Rhabdoid tumor of the kidney: a rare malignant neoplasm of infancy. A case report and review of the literature] 135
Hemophagocytic lymphohistiocytosis and visceral leishmaniasis in children: case report and systematic review of literature 132
Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study 131
Rechallenge to carboplatin in children with low grade glioma and carboplatin hypersensitivity reactions 131
Interactions between antiepileptic and chemoterapeutic drugs in children with brain tumors: is it time to change treatment? 130
A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies 128
Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia 126
Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia 126
Hematological disorders in children with Down syndrome 125
Cisplatin-induced nephrotoxicity in children: what is the best protective strategy? 123
Severe Hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome. 117
Evaluation of Metabolic and Cardiovascular Risk Measured by Laboratory Biomarkers and Cardiopulmonary Exercise Test in Children and Adolescents Recovered from Brain Tumors: The CARMEP Study 116
Undifferentiated Embryonal Sarcoma of the Liver (UESL) in Adolescents: An Unexpected Diagnosis 113
Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia 111
Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study 110
Psychological Experiences of Parents of Pediatric Cancer Patients during and after COVID-19 Pandemic 110
Serum biomarkers for sepsis in children with febrile neutropenia and cancer 107
Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors 106
Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response 105
Correction to: Multimodal treatment of pediatric patients with Askin's tumors: Our experience (World Journal of Surgical Oncology (2018) 16 (140) DOI: 10.1186/s12957-018-1434-2) 104
Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors 101
The Role of the Cerebellum in Advanced Cognitive Processes in Children 100
Temozolomide and oral etoposide in children with recurrent malignant brain tumors 100
Multimodal treatment of pediatric patients with Askin's tumors: Our experience 99
Bisphosphonates: From Pharmacology to Treatment 98
Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children with Ewing Sarcoma 98
Management of Oral Mucositis in Children With Malignant Solid Tumors 98
Pediatric low-grade glioma and neurofibromatosis type 1: A single-institution experience 96
Mechanisms, characteristics and treatment of neuropathic pain and peripheral neuropathy associated with dinutuximab in neuroblastoma patients 96
Pathogenic G6PD variants: Different clinical pictures arise from different missense mutations in the same codon 96
RELEASE MECHANISMS OF {[I-125]METAIODOBENZYLGUANIDINE IN NEUROBLASTOMA-CELLS - EVIDENCE OF A CARRIER-MEDIATED EFFLUX} 96
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors 94
Neuroblastoma with symptomatic epidural compression in the infant: The AIEOP experience 93
Oral Microbiota during Childhood and Its Role in Chemotherapy-Induced Oral Mucositis in Children with Cancer 91
Growth hormone replacement therapy in pediatric brain tumor survivors 90
Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients 89
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients 89
Pregnancy-associated Cancer and Chemotherapy during Pregnancy 88
Role of Partial Splenectomy in Hematologic Childhood Disorders 87
Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies 86
Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed) 85
Neuroblastoma in the first year of life. The Italian contribution to a study of the Internation Society of Paediatric Oncology Europe Neuroblastoma Group 85
Gynecological cancer among adolescents and young adults (AYA) 85
Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma 81
Multifocal infantile haemangiomatosis with hepatic involvement: Two cases and treatment management 81
Anthropometric parameters as a tool for the prediction of metabolic and cardiovascular risk in childhood brain tumor survivors 79
Role of 131I-Metaiodobenzylguanidine in the treatment of neuroblastoma 79
Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy 78
Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials? 76
Cytotoxicity and resistance mechanisms of cisplatin 75
Pharmacology and scheduling of Temozolomide 75
Treatment of advanced neuroblastoma: Feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy 74
Late anthracycline cardiotoxicity in pediatric age 74
Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low-body weight child: A case report 74
Anthracycline-related cardiotoxicity: Risk factors and therapeutic options in childhood cancers 73
Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia 71
131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma 70
Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III protein C, protein S 70
Tyrosine Kinase Inhibitors and Thyroid Toxicity 69
Hypersensitivity reactions to platinum drugs 69
The DNA-topoisomerase Inhibitors in Cancer Therapy 69
Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine 69
Treatment and Long-Term Sequelae in Childhood Brain Tumors 68
Cisplatin Toxicity in Children with Malignancy 66
Management of Children with Optic Gliomas and Neurofibromatosis Type 1 65
Vincristine-induced peripheral neuropathy (Vipn) in pediatric tumors: Mechanisms, risk factors, strategies of prevention and treatment 65
Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy 61
Chemotherapy of medulloblastoma 57
Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment 55
Nutritional status in the pediatric oncology patients 54
Special Issue: Childhood Brain Cancer Treatment 53
Totale 11.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022554 54 62 14 39 29 17 6 78 24 27 104 100
2022/20231.256 135 149 76 191 59 166 69 131 162 23 51 44
2023/2024770 42 214 28 56 31 91 37 25 14 61 68 103
2024/20252.432 22 41 137 62 295 98 71 149 374 271 516 396
2025/20265.778 890 196 410 636 883 276 1.076 306 406 371 253 75
Totale 12.764